| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.43 | 0.001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.007 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-06 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |